(Hedgeweek) The frantic hunt for an effective vaccine against coronavirus could leave some pharmaceutical companies highly exposed in a fiercely competitive race – and UK hedge fund Argonaut Capital is weighing in with several key bets against the sector.
Why this hedge fund manager is betting against drug companies in the race for a Covid vaccine
This entry was posted in Syndicated. Bookmark the permalink.
